{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:42:33Z","timestamp":1777005753348,"version":"3.51.4"},"reference-count":109,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DK127638-05"],"award-info":[{"award-number":["1R01DK127638-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DK135265-04"],"award-info":[{"award-number":["1R01DK135265-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The mechanism of kidney injury associated with apolipoprotein L1 (APOL1) risk variants has remained elusive. Complicating this issue is the broad clinical spectrum of APOL1 kidney disease, which has engendered speculation that this reflects multiple mechanisms of kidney injury. APOL1 kidney disease can be rapid in onset with heavy proteinuria, associated with viral infections and categorized pathologically as collapsing focal segmental glomerulosclerosis. Alternatively, APOL1 kidney disease also may present as an insidious, slowly progressive disease, with less proteinuria but losses in glomerular filtration rate and with varied pathology. In addition to APOL1 kidney disease, APOL1 risk variants are also associated with preeclampsia and other conditions related to placental insufficiency. The outcome of these APOL1-associated pregnancy complications frequently results in prematurity and low birth weight, both of which are known risk factors for hypertension and kidney disease later in life due to reduced nephron endowment. The significance of APOL1 risk variants on pregnancy complications that predispose to kidney disease should not be overlooked as a central mechanism of APOL1 kidney disease, especially the insidious forms, which are difficult to distinguish from the spectrum of kidney disease attributable to prematurity and low birth weight. If low nephron endowment is a causal mechanism behind some forms of APOL1 kidney disease, this may have an impact on clinical trials evaluating drugs directly inhibiting APOL1, since in these instances, ongoing APOL1 expression may not be driving podocyte loss and progressive kidney dysfunction.<\/jats:p>","DOI":"10.3390\/cells14171373","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:07:32Z","timestamp":1756901252000},"page":"1373","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Insidious APOL1 Kidney Disease: A Manifestation of APOL1-Associated Pregnancy Complications on Nephron Endowment?"],"prefix":"10.3390","volume":"14","author":[{"given":"Timur","family":"Azhibekov","sequence":"first","affiliation":[{"name":"Division of Neonatology, Cleveland Clinic Children\u2019s, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5874-705X","authenticated-orcid":false,"given":"Leslie A.","family":"Bruggeman","sequence":"additional","affiliation":[{"name":"Department of Inflammation & Immunity, Cleveland Clinic Research, Cleveland, OH 44195, USA"},{"name":"School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2010.251","article-title":"A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9","volume":"78","author":"Genovese","year":"2010","journal-title":"Kidney Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1681\/ASN.2015111220","article-title":"APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease","volume":"27","author":"Bruggeman","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101162","DOI":"10.1016\/j.preghy.2024.101162","article-title":"Association of genetic ancestry with pre-eclampsia in multi-ethnic cohorts of pregnant women","volume":"38","author":"Gill","year":"2024","journal-title":"Pregnancy Hypertens."},{"key":"ref_6","first-page":"649","article-title":"Gestational Hypertension and Preeclampsia: A Practice Bulletin from ACOG","volume":"100","author":"Croke","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jch.13514","article-title":"The burden of hypertensive disorders of pregnancy in Africa: A systematic review and meta-analysis","volume":"21","author":"Noubiap","year":"2019","journal-title":"J. Clin. Hypertens."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Miller, A.K., Azhibekov, T., O\u2019Toole, J.F., Sedor, J.R., Williams, S.M., Redline, R.W., and Bruggeman, L.A. (2020). Association of preeclampsia with infant APOL1 genotype in African Americans. BMC Med. Genet., 21.","DOI":"10.1186\/s12881-020-01048-4"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000529850","article-title":"Fetal High-Risk APOL1 Genotype Increases Risk for Small for Gestational Age in Term Infants Affected by Preeclampsia","volume":"120","author":"Azhibekov","year":"2023","journal-title":"Neonatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ajhg.2018.08.002","article-title":"Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry","volume":"103","author":"Reidy","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1053\/j.ajkd.2020.10.020","article-title":"Joint Associations of Maternal-Fetal APOL1 Genotypes and Maternal Country of Origin with Preeclampsia Risk","volume":"77","author":"Hong","year":"2021","journal-title":"Am. J. Kidney Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Sheehy, S., Friedman, D., Liu, C., Lunetta, K.L., Zirpoli, G., and Palmer, J.R. (2025). Association between Apolipoprotein L1 genetic variants and risk of preeclampsia and preterm birth among U.S. Black women. Eur. J. Obstet. Gynecol. Reprod. Biol. X, 25.","DOI":"10.1016\/j.eurox.2025.100365"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2020.01.034","article-title":"Maternal variants within the apolipoprotein L1 gene are associated with preeclampsia in a South African cohort of African ancestry","volume":"246","author":"Winkler","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021119-034345","article-title":"APOL1 and Kidney Disease: From Genetics to Biology","volume":"82","author":"Friedman","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ki.2012.111","article-title":"HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics","volume":"82","author":"Atta","year":"2012","journal-title":"Kidney Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1681\/ASN.2011060562","article-title":"APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease","volume":"23","author":"Fine","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.kint.2020.01.018","article-title":"The spectrum of kidney biopsy findings in HIV-infected patients in the modern era","volume":"97","author":"Kudose","year":"2020","journal-title":"Kidney Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.34067\/KID.0000000000000290","article-title":"Local Inflammation But Not Kidney Cell Infection Associated with High APOL1 Expression in COVID-Associated Nephropathy","volume":"4","author":"Nguyen","year":"2023","journal-title":"Kidney360"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.2020060804","article-title":"COVID-19-Associated Glomerular Disease","volume":"32","author":"Shetty","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.kint.2021.07.015","article-title":"A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19)","volume":"100","author":"May","year":"2021","journal-title":"Kidney Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1681\/ASN.2020060802","article-title":"Kidney Biopsy Findings in Patients with COVID-19","volume":"31","author":"Kudose","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Muehlig, A.K., Gies, S., Huber, T.B., and Braun, F. (2021). Collapsing Focal Segmental Glomerulosclerosis in Viral Infections. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.800074"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Khalaila, R., and Skorecki, K. (2025). Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell Injury. Cells, 14.","DOI":"10.3390\/cells14131011"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1681\/ASN.0000000000000368","article-title":"In Search of the Mechanism of APOL1 Kidney Disease","volume":"35","author":"Friedman","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1681\/ASN.0000000000000367","article-title":"The Mechanism of Kidney Disease due to APOL1 Risk Variants: Involvement of Two Distinct Processes","volume":"35","author":"Pays","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MNH.0000000000001068","article-title":"APOL1-associated kidney disease: Modulators of the genotype-phenotype relationship","volume":"34","author":"Pollak","year":"2025","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"H\u00f6ffken, V., Braun, D.A., Pavenst\u00e4dt, H., and Weide, T. (2025). A Cell Biologist\u2019s View on APOL1: What We Know and What We Still Need to Address. Cells, 14.","DOI":"10.3390\/cells14130960"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e1325","DOI":"10.34067\/KID.0000000000000216","article-title":"Nonpodocyte Roles of APOL1 Variants: An Evolving Paradigm","volume":"4","author":"Pell","year":"2023","journal-title":"Kidney360"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ojo, A.O., Adu, D., Bramham, K., Freedman, B.I., Gbadegesin, R.A., Ilori, T.O., Jefferson, N., Olabisi, O.A., Susztak, K., and Young, B.A. (2025). APOL1 kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int., in press.","DOI":"10.1016\/j.kint.2025.05.017"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM200106283442604","article-title":"Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection","volume":"344","author":"Winston","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"dmm048952","DOI":"10.1242\/dmm.048952","article-title":"Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease","volume":"14","author":"McCarthy","year":"2021","journal-title":"Dis. Model. Mech."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e2210150119","DOI":"10.1073\/pnas.2210150119","article-title":"ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit","volume":"119","author":"Riella","year":"2022","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e126124","DOI":"10.1172\/jci.insight.126124","article-title":"Antisense oligonucleotide treatment ameliorates IFN-gamma-induced proteinuria in APOL1-transgenic mice","volume":"4","author":"Aghajan","year":"2019","journal-title":"JCI Insight"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-\u03b1, -\u03b2, or -\u03b3 is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa2202396","article-title":"Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants","volume":"388","author":"Egbuna","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e157432","DOI":"10.1172\/jci.insight.157432","article-title":"JAK inhibitor blocks COVID-19 cytokine-induced JAK\/STAT\/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids","volume":"7","author":"Nystrom","year":"2022","journal-title":"JCI Insight"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.kint.2024.07.026","article-title":"Differing sensitivities to angiotensin converting enzyme inhibition of kidney disease mediated by APOL1 high-risk variants G1 and G2","volume":"106","author":"Jacas","year":"2024","journal-title":"Kidney Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00467-014-3031-0","article-title":"Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease","volume":"30","author":"Anyaegbu","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic Utility of Exome Sequencing for Kidney Disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans","volume":"83","author":"Lipkowitz","year":"2013","journal-title":"Kidney Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/ndt\/gfr796","article-title":"APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease","volume":"27","author":"Tzur","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/ki.2012.217","article-title":"Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease","volume":"82","author":"Freedman","year":"2012","journal-title":"Kidney Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000353223","article-title":"High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria","volume":"123","author":"Ulasi","year":"2013","journal-title":"Nephron Clin. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00426.2018","article-title":"APOL1 polymorphisms and kidney disease: Loss-of-function or gain-of-function?","volume":"316","author":"Bruggeman","year":"2019","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1681\/ASN.2020111629","article-title":"COVID-19 and APOL1: Understanding Disease Mechanisms through Clinical Observation","volume":"32","author":"Friedman","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1681\/ASN.2013111242","article-title":"Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial","volume":"26","author":"Kopp","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/modpathol.2014.92","article-title":"Histopathologic findings associated with APOL1 risk variants in chronic kidney disease","volume":"28","author":"Larsen","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1007\/s00467-021-04990-4","article-title":"APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis","volume":"36","author":"Zee","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e161316","DOI":"10.1172\/jci.insight.161316","article-title":"Low nephron endowment increases susceptibility to renal stress and chronic kidney disease","volume":"8","author":"Good","year":"2023","journal-title":"JCI Insight"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2215\/CJN.01700408","article-title":"Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis","volume":"4","author":"Hodgin","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/archinte.160.10.1472","article-title":"Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States","volume":"160","author":"Lackland","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2007020252","article-title":"Low birth weight increases risk for end-stage renal disease","volume":"19","author":"Vikse","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000353898","article-title":"Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis","volume":"38","author":"Ikezumi","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1","volume":"66","author":"Freedman","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2215\/CJN.0000000000000070","article-title":"Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype","volume":"18","author":"Chen","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1681\/ASN.0000000000000094","article-title":"Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes","volume":"34","author":"Elliott","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Okocha","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3324\/haematol.2015.124875","article-title":"Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy","volume":"100","author":"Saraf","year":"2015","journal-title":"Haematologica"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/ki.2011.459","article-title":"Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease","volume":"81","author":"Orskov","year":"2012","journal-title":"Kidney Int."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ruggajo, P., Svarstad, E., Leh, S., Marti, H.P., Reis\u00e6ther, A.V., and Vikse, B.E. (2016). Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy\u2014A Retrospective Registry-Based Cohort Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153819"},{"key":"ref_67","first-page":"875","article-title":"Weight at birth and other factors influencing progression of idiopathic membranous nephropathy","volume":"9","author":"Duncan","year":"1994","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1046\/j.1523-1755.1998.00121.x","article-title":"Unfavorable course of minimal change nephrotic syndrome in children with intrauterine growth retardation","volume":"54","author":"Zidar","year":"1998","journal-title":"Kidney Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2215\/CJN.0000000000000069","article-title":"Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes","volume":"18","author":"Kallash","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1542\/peds.2014-3819","article-title":"Neonatal Acute Kidney Injury","volume":"136","author":"Selewski","year":"2015","journal-title":"Pediatrics"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/MOP.0000000000000607","article-title":"Prematurity and future kidney health: The growing risk of chronic kidney disease","volume":"30","author":"Starr","year":"2018","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s00467-023-05958-2","article-title":"Reduced kidney function and hypertension in adolescents with low birth weight, NHANES 1999\u20132016","volume":"38","author":"Brathwaite","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/003335490612100304","article-title":"The association of low birthweight and chronic renal failure among Medicaid young adults with diabetes and\/or hypertension","volume":"121","author":"Fan","year":"2006","journal-title":"Public Health Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2215\/CJN.04080320","article-title":"Intrauterine Growth Restriction and Risk of Diverse Forms of Kidney Disease during the First 50 Years of Life","volume":"15","author":"Gjerde","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/j.ajkd.2015.11.015","article-title":"Familial Factors, Low Birth Weight, and Development of ESRD: A Nationwide Registry Study","volume":"67","author":"Ruggajo","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"l1346","DOI":"10.1136\/bmj.l1346","article-title":"Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: National cohort study","volume":"365","author":"Crump","year":"2019","journal-title":"Br. Med. J."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Yoshida, T., Latt, K.Z., Shrivastav, S., Lu, H., Reidy, K.J., Charlton, J.R., Zhao, Y., Winkler, C.A., Reznik, S.E., and Rosenberg, A.Z. (2024). Preeclampsia in mice carrying fetuses with APOL1 risk variants. bioRxiv.","DOI":"10.1101\/2024.03.20.586039"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-2275(20)31171-8","article-title":"Apolipoprotein L gene family: Tissue-specific expression, splicing, promoter regions; discovery of a new gene","volume":"42","author":"Duchateau","year":"2001","journal-title":"J. Lipid Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1172\/JCI200422991","article-title":"Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface","volume":"114","author":"Zhou","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/HYPERTENSIONAHA.113.01892","article-title":"Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: Relationship to clinical outcome","volume":"62","author":"Lyall","year":"2013","journal-title":"Hypertension"},{"key":"ref_81","first-page":"1","article-title":"Births: Final Data for 2022","volume":"73","author":"Osterman","year":"2024","journal-title":"Natl. Vital. Stat. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ekir.2019.03.006","article-title":"APOL1-Associated Kidney Disease in Brazil","volume":"4","author":"Riella","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ajog.2013.10.879","article-title":"Pregnancy, parturition and preeclampsia in women of African ancestry","volume":"210","author":"Nakimuli","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/jp.2016.73","article-title":"Preterm preeclampsia in relation to country of birth","volume":"36","author":"Ray","year":"2016","journal-title":"J. Perinatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1701-2163(16)35215-X","article-title":"Serious preeclampsia among different immigrant groups","volume":"34","author":"Urquia","year":"2012","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_86","first-page":"2051","article-title":"An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts","volume":"32","author":"Robertson","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s10995-014-1571-3","article-title":"Fetal sex and race modify the predictors of fetal growth","volume":"19","author":"Reynolds","year":"2015","journal-title":"Matern. Child Health J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/AOG.0000000000000451","article-title":"Clinical risk factors for preeclampsia in the 21st century","volume":"124","author":"Parry","year":"2014","journal-title":"Obstet. Gynecol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2105\/AJPH.2005.068577","article-title":"Racial disparity in hypertensive disorders of pregnancy in New York State: A 10-year longitudinal population-based study","volume":"97","author":"Tanaka","year":"2007","journal-title":"Am. J. Public Health"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s10995-012-1162-0","article-title":"Racial disparities in economic and clinical outcomes of pregnancy among Medicaid recipients","volume":"17","author":"Zhang","year":"2013","journal-title":"Matern. Child Health J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0140-6736(17)30576-7","article-title":"A developmental approach to the prevention of hypertension and kidney disease: A report from the Low Birth Weight and Nephron Number Working Group","volume":"390","author":"Luyckx","year":"2017","journal-title":"Lancet"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00467-016-3384-7","article-title":"Prevalence of chronic kidney disease risk factors among low birth weight adolescents","volume":"31","author":"Khalsa","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"ref_93","first-page":"983","article-title":"APOL1-associated glomerular disease among African-American children: A collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts","volume":"32","author":"Ng","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2215\/CJN.0000000000000475","article-title":"Association of Preterm Birth with Adverse Glomerular Disease Outcomes in Children and Adults","volume":"19","author":"Isaac","year":"2024","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1007\/s00467-023-05876-3","article-title":"The association of low birthweight and prematurity on outcomes in children and adults with nephrotic syndrome-a NEPTUNE cohort study","volume":"38","author":"Hingorani","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41581-022-00668-8","article-title":"The impact of intrauterine growth restriction and prematurity on nephron endowment","volume":"19","author":"Sutherland","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1471-0528.1992.tb13726.x","article-title":"The effect of intrauterine growth retardation on the development of renal nephrons","volume":"99","author":"Hinchliffe","year":"1992","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00041552-199309000-00001","article-title":"Congenital oligonephropathy: An inborn cause of adult hypertension and progressive renal injury?","volume":"2","author":"Brenner","year":"1993","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_99","first-page":"F85","article-title":"Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation","volume":"241","author":"Hostetter","year":"1981","journal-title":"Am. J. Physiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1681\/ASN.2005010055","article-title":"Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene","volume":"16","author":"Wharram","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1681\/ASN.2005050488","article-title":"Podocyte hypertrophy, \u201cadaptation,\u201d and \u201cdecompensation\u201d associated with glomerular enlargement and glomerulosclerosis in the aging rat: Prevention by calorie restriction","volume":"16","author":"Wiggins","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2215\/CJN.05650516","article-title":"Glomerular Density and Volume in Renal Biopsy Specimens of Children with Proteinuria Relative to Preterm Birth and Gestational Age","volume":"12","author":"Koike","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Zhang, L., Chen, Z., Gao, Q., Liu, G., Zheng, J., and Ding, F. (2023). Preterm birth leads to a decreased number of differentiated podocytes and accelerated podocyte differentiation. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1142929"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Bruggeman, L.A., Wu, Z., Luo, L., Madhavan, S., Drawz, P.E., Thomas, D.B., Barisoni, L., O\u2019Toole, J.F., and Sedor, J.R. (2019). APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy. PLoS ONE, 14.","DOI":"10.1101\/598557"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e14234","DOI":"10.1111\/ctr.14234","article-title":"Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation","volume":"35","author":"Chen","year":"2021","journal-title":"Clin. Transplant."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1681\/ASN.2014080768","article-title":"APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study","volume":"26","author":"Hoy","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1681\/ASN.2021070998","article-title":"Estimating Nephron Number from Biopsies: Impact on Clinical Studies","volume":"33","author":"Morozov","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2215\/CJN.0000000000000256","article-title":"APOL1 Kidney Disease: Discovery to Targeted Therapy in 10 Years","volume":"19","author":"Sedor","year":"2024","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.kint.2025.03.031","article-title":"Postpartum counseling and interventions to reduce the risk of chronic kidney disease: Back to the future","volume":"108","author":"Piccoli","year":"2025","journal-title":"Kidney Int."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1373\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:38:41Z","timestamp":1760035121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":109,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cells14171373"],"URL":"https:\/\/doi.org\/10.3390\/cells14171373","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}